Skip to main content
SpringerLink
Log in

Psychotropic Drug Use in Pregnancy

  • Chapter
The Practitioner’s Guide to Psychoactive Drugs

Abstract

The pregnant psychiatric patient on or requiring psychotropic medication presents an unusual clinical dilemma, often placing the physician between a teratologic rock and a clinical hard place.1 Although ethical considerations have precluded adequately controlled studies with pregnant woman, the rate of psychotropic use in pregnancy2,3 together with the prevalence of certain psychiatric conditions in women during pregnancy4 and in women of childbearing potential5 in general underscore the need for treatment guidelines to help clinicians manage pregnant patients with psychiatric disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cohen L. S., Heller V. L., Rosenbaum J. F.: Treatment guidelines for psychotropic drug use in pregnancy. Psychosomatics 30:25–33, 1989.

    Article  PubMed  CAS  Google Scholar 

  2. Doering J. C., Stewart R. B.: The extent and character of drug consumption during pregnancy. JAMA 239:843–846, 1978.

    Article  PubMed  CAS  Google Scholar 

  3. Kasilo O., Romero M., Bonati M., et al: Information on drug use in pregnancy from the Viewpoint Regional Drug Information Center. Eur J Clin Pharmacol 35:447–453, 1988.

    Article  PubMed  CAS  Google Scholar 

  4. O’Hara M. W., Zekoski E. M., Phillips L. H., et al: A controlled prospective study of postpartum mood disorders: Comparison of childbearing and nonchildbearing women. J Abnorm Psychol (in press).

    Google Scholar 

  5. Frank E., Kupfer D. J., Jacob M., et al: Pregnancy related affective episodes among women with recurrent depression. Am J Psychiatry 144:288–293, 1987.

    PubMed  CAS  Google Scholar 

  6. Calabrese J. R., Gulledge A. D.: Psychotropics during pregnancy and lactation: A review. Psychosomatics 26:413–426, 1985.

    Article  PubMed  CAS  Google Scholar 

  7. Robinson G. E., Stewart D. E., Flak E.: The rational use of psychotropic drugs in pregnancy and postpartum. Can J Psychiatry 31:183–190, 1986.

    PubMed  CAS  Google Scholar 

  8. Slone D., Siskind V., Heinonen O. P., et al: Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality age, birth weight and intelligence quotient score. Am J Obstet Gynecol 128:486–488, 1977.

    PubMed  CAS  Google Scholar 

  9. Rumeau-Rouguette C., Goujard J., Huel G.: Possible teratogenic effect of phenothiazines in human beings. Teratology 15:57–64, 1977.

    Article  Google Scholar 

  10. Milkovich L., Van den Berg B. J.: An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstet Gynecol 125:244–248, 1976.

    PubMed  CAS  Google Scholar 

  11. Edlund M. J., Craig T. J.: Antipsychotic drug use and birth defects: An epidemiologic reassessment. Compr Psychiatry 25:32–37, 1984.

    Article  PubMed  CAS  Google Scholar 

  12. Kuenssberg E. V., Knox J. D.: Imipramine in pregnancy. Br Med J 2:292, 1972.

    Article  PubMed  CAS  Google Scholar 

  13. Idanpaan-Heikkila J., Saxen L.: Possible teratogenicity of imipramine-chloropyramine. Lancet 2:282–284, 1973.

    Article  PubMed  CAS  Google Scholar 

  14. Czeizel A., Lendvay A.: In-utero exposure to benzodiazepines (letter). Lancet 1:628, 1987.

    Google Scholar 

  15. Rosenberg L., Mitchell A., Parsells J., et al: Lack of relation of oral cleft to diazepam use during pregnancy. N Engl J Med 309:1282–1285, 1983.

    Article  PubMed  CAS  Google Scholar 

  16. Shiono B. H., Mills J. L.: Oral clefts and diazepam use during pregnancy (letter). N Engl J Med 311:919–920, 1984.

    Article  PubMed  CAS  Google Scholar 

  17. Langman J.: Human development-normal and abnormals, in Langman J. (ed.): Medical Embryology (ed. 5). Baltimore, Williams & Wilkins, 1985, p 123.

    Google Scholar 

  18. Dicke J. M.: Teratology: Principles and practice. Med Clin North Am 73:567–581, 1989.

    PubMed  CAS  Google Scholar 

  19. Coyle I. R.: Changes in developing behavior following prenatal administration of imipramine. Pharmacol Biochem Behav 3:799–807, 1975.

    Article  PubMed  CAS  Google Scholar 

  20. Robertson R. T., Majka J. A., Peter C. P., et al: Effects of prenatal exposure to chlorpromazine on postnatal development and behavior of rats. Toxicol Appl Pharmacol 53:541–549, 1980.

    Article  PubMed  CAS  Google Scholar 

  21. Kellogg C., Ison J., Miller R.: Prenatal diazepam exposure: Effects on auditory temporal resolution in rats. Psychopharmacology 79:332–337, 1983.

    Article  PubMed  CAS  Google Scholar 

  22. Miller G. C., Friedhoff A. G.: Prenatal neurotransmitter programming of postnatal receptor function. Prog Brain Res 2:509–522, 1987.

    Google Scholar 

  23. Webster P. A. C.: Withdrawal symptoms in neonates associated with maternal antidepressant therapy. Lancet 2:318–319, 1973.

    Article  PubMed  CAS  Google Scholar 

  24. Shearer W. T., Schreiner R. L., Marshall R. E.: Urinary retention in a neonate secondary to maternal ingestion of nortriptyline. J Pediatr 81:570–572, 1972.

    Article  PubMed  CAS  Google Scholar 

  25. Cree J. E., Meyer J., Hailey D. M.: Diazepam in labour: Its metabolism and effect on the clinical condition and thermogenesis of the newborn. Br Med J 4:251–255, 1973.

    Article  PubMed  CAS  Google Scholar 

  26. Hill R. M., Desmond M. M., Kay J. L.: Extrapyramidal dysfunction in an infant of a schizophrenic mother. J Pediatr 69:589–595, 1966.

    Article  PubMed  CAS  Google Scholar 

  27. Tamer A., McKey R., Arias D., et al: Phenothiazine-induced extrapyramidal dysfunction in the neonate. J Pediatr 7:479–480, 1969.

    Google Scholar 

  28. Levy W., Wisniewski K.: Chlorpromazine causing extrapyramidal dysfunction in newborn infants of psychotic mothers. NY State J Med 74:684–685, 1974.

    CAS  Google Scholar 

  29. Gelenberg A. J.: Pregnancy, psychotropic drugs, and psychiatric disorders. Psychosomatics 27:216–217, 1986.

    Article  PubMed  CAS  Google Scholar 

  30. Gelenberg A. J.: Psychotropic drugs during pregnancy and the perinatal period. Biol Ther Psychiatry 2:41–42, 1979.

    Google Scholar 

  31. Nahas C., Goujard J.: Phenothiazines, benzodiazepines and the fetus, in Scarpelli E. M., Cosmi E. V. (eds): Reviews in Perinatal Medicine. New York, Raven Press, 1978, pp 243–280.

    Google Scholar 

  32. Rivera-Calimlin L.: The significance of drugs in breastmilk: Pharmacokinetic considerations. Clin Perinatol 14:51–70, 1987.

    Google Scholar 

  33. Anderson P. O., McGuire G. G.: Neonatal alprazolam withdrawal-possible effects of breast feeding. Drug Intell Clin Pharm 23:614, 1989.

    CAS  Google Scholar 

  34. Gelenberg A. J.: Antidepressants in milk. Biol Ther Psychiatry 10:1, 1987.

    Google Scholar 

  35. Charney D., Heninger G.: Abnormal regulation of noradrenergic function in panic disorder. Arch Gen Psychiatry 43:1042–1054, 1986.

    Article  PubMed  CAS  Google Scholar 

  36. Siever L., Uhde T.: New studies and perspectives on the noradrenergic receptor system in depression: Effects of the alpha two adrenergic agonist clonidine. Biol Psychiatry 19:131–156, 1984.

    PubMed  CAS  Google Scholar 

  37. Cohen L. S., Rosenbaum J. F., Heller V. L.: Panic attack-associated placental abruption: A case report. J Clin Psychiatry 50:266–267, 1989.

    PubMed  CAS  Google Scholar 

  38. Avant K.: Anxiety as a potential factor affecting maternal attachment. J Obstet Gynecol Neonatal Nurs 10:416–419, 1981.

    Article  CAS  Google Scholar 

  39. Brazelton T. B.: Mother infant reciprocity, in Klaus M. H., Leger T., Trause M. A. (eds): Maternal Attachment and Mothering Disorders: A Roundtable. North Brunswick, NJ, Johnson & Johnson, 1975.

    Google Scholar 

  40. Zahn-Waxler C., Cummings E. M., Ianoff R. J., et al: Young offspring of depressed patients: A population of risk for affective problems and childhood depression, in Cichetti D., C Schneider-Rosen (eds): Childhood Depression. San Francisco, Jossey-Bass, 1984.

    Google Scholar 

  41. Cogill S. R., Caplan H. L., Alexandra H., et al: Impact of maternal depression of cognitive development of young children. Br Med J 292:1165–1167, 1986.

    Article  CAS  Google Scholar 

  42. Sapolsky R.: Stress glucocorticoids and the rate of brain aging. Presented at Annual Meeting of the American College of Neuropsychopharmacology, December, 1988, Nashville, TN.

    Google Scholar 

  43. Protheroe C.: Puerperal psychoses: A long term study 1927–1961. Br J Psychiatry 115:9–30, 1961.

    Article  Google Scholar 

  44. Kopelman A. E., McCullar F. W., Heggeness, L.: Limb malformations following maternal use of haloperidol. JAMA 231:62–64, 1975.

    Article  Google Scholar 

  45. Scokel P. W., Jones W. D.: Infant jaundice after phenothiazine drugs for labour: An enigma. Obstet Gynecol 20:124–127, 1962.

    Article  PubMed  CAS  Google Scholar 

  46. Falterman L. G., Richardson D. J.: Small left colon syndrome associated with maternal ingestion of psychotropics. J Pediatr 97:300–310, 1980.

    Google Scholar 

  47. Spear L. P., Shalaby I. A., Brick J.: Chronic administration of haloperidol during development: Behavioral and psychopharmacological effects. Psychopharmacology 70:47–58, 1980.

    Article  PubMed  CAS  Google Scholar 

  48. Desmond M. M., Rudolph A. J., Hill R. M., et al: Behavioral alterations in infants born to mothers on psychoactive medication during pregnancy, in Farrell G. (ed): Congenital Mental Retardation. Austin, University of Texas, 1967.

    Google Scholar 

  49. Platt J. E., Friedhoff A. J., Broman S. H., et al: Effects of prenatal exposure to neuroleptic drugs on childrens growth. Neuropsychopharmacology 1:205–212, 1988.

    Article  PubMed  CAS  Google Scholar 

  50. Kris E. B.: Children of mothers maintained on pharmacotherapy during pregnancy and postpartum. Curr Ther Res 31:690–695, 1965.

    Google Scholar 

  51. Zajicek E.: Psychiatric problems during pregnancy, in Wolkind S., Zajicek E. (eds): Pregnancy: A Psychological and Social Study. London, Academic Press, 1981, pp 57–73.

    Google Scholar 

  52. O’Hara M. W., Neunaber D. J., Zekoski E. M.: Prospective study of postpartum depression: Prevalence, course, and predictive factors. J Abnorm Psychol 93:158–171, 1984.

    Article  PubMed  Google Scholar 

  53. O’Hara M. W.: Social support, life events, and depression during pregnancy and the puerperium. Arch Gen Psychiatry 43:573, 1986.

    Google Scholar 

  54. O’Hara M. W.: Postpartum blues, depression, and psychosis: A review. J Psychosom Obstet Gynecol 7:205–227, 1987.

    Article  Google Scholar 

  55. Targum S. D., Gershon E. S.: Pregnancy, genetic counselling and the major psychiatric disorders, in genetic diseases, in Schulman J., Simpson J. (eds): Pregnancy-Maternal Effects and Fetal Outcome. New York, Academic Press, 1981.

    Google Scholar 

  56. Akiskal H. S., Walker P., Puzantian V. R., et al: Bipolar outcome in the course of depressive illness: Phenomenologic, familiar, and pharmacologic predictors. J Affect Disord 5:115–128, 1983.

    Article  PubMed  CAS  Google Scholar 

  57. McBride W. G.: Limb deformities associated with iminodibenzyl hydrochloride (letter). Med J Aust 1:492, 1972.

    PubMed  CAS  Google Scholar 

  58. Crombie D., Pinsent R. J., Felming D.: Imipramine and pregnancy. Br Med J 1:745, 1972.

    Article  PubMed  CAS  Google Scholar 

  59. Coyle I. R., Singer G.: The interaction of post-weaning housing conditions and prenatal drug effects of behavior. Psychopharmacology 41:237–244, 1975.

    Article  CAS  Google Scholar 

  60. Giller E., Bialos D., Riddle M., et al: Monoamine oxidase inhibitor responsive depression. Psychiatry Res 6:41–48, 1982.

    Article  PubMed  CAS  Google Scholar 

  61. Liebowitz M. R., Quitkin F., Stewart J., et al: Phenelzine vs. imipramine in atypical depression. Arch Gen Psychiatry 41:669–677, 1984.

    Article  PubMed  CAS  Google Scholar 

  62. Poulson E., Robson J. M.: Effect of phenelzine and some related compounds in pregnancy. J Endocrinol 30:205–215, 1964.

    Article  PubMed  CAS  Google Scholar 

  63. Quitkin F. M.: The importance of dosage in prescribing antidepressants. Br J Psychiatry 147:593–597, 1985.

    Article  PubMed  CAS  Google Scholar 

  64. Schou, M. Concerning the start of the Scandinavian Register of Lithium Babies. Acta Psychiatr Scand 207(suppl.):96–97, 1969.

    Google Scholar 

  65. Ackerman D., Jefferson J., Griest J., et al: The lithium index: An innovative approach to consultation by computer. Am J Psychiatry 141:415–417, 1984.

    PubMed  CAS  Google Scholar 

  66. Weinstein M. R., Goldfield M. D.: Cardiovascular malformations with lithium use during pregnancy. Am J Psychiatry 132:529–531, 1975.

    PubMed  CAS  Google Scholar 

  67. Kirklin J. W., Barratt-Boyes B. G.: Ebstein’s malformation, in Kirklin J. W., Barratt-Boyes B. G. (eds): Cardiac Surgery. New York, John Wiley & Sons, 1986, pp 889–907.

    Google Scholar 

  68. Elia J., Katz I. R., Simpson G. M.: Teratogenicity of psychotherapeutic medications. Psychopharmacol Bull 23:531–585, 1987.

    PubMed  CAS  Google Scholar 

  69. van Gent E. M., Nabarro G.: Haloperidol as an alternative to lithium in pregnant women (letter). Am J Psychiatry 144:1241, 1987.

    PubMed  Google Scholar 

  70. Post R. M., Uhde T. W., Ballenger J. C., et al: Prophylactic efficacy of carbamazapine in manic— depressive illness. Am J Psychiatry 140:1602–1604, 1983.

    PubMed  CAS  Google Scholar 

  71. Prien R. F., Gelenberg A. J.: Alternatives to lithium for preventive treatment of bipolar disorder, Am J Psychiatry 146:840–848, 1989.

    PubMed  CAS  Google Scholar 

  72. Nidely J. R., Blake D. A., Freeman J. M., et al: Carbamazapine levels in pregnancy and lactation. Obstet Gynecol 53:139–140, 1979.

    Google Scholar 

  73. Nakne Y., Okuma T., Takahashi R., et al: Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: A report of a collaborative study group in Japan. Epilepsia 21:663–680, 1980.

    Article  Google Scholar 

  74. Paulson G. W., Paulson R. B.: Teratogenic effects of anticonvulsants. Arch Neurol 40:140–143, 1981.

    Article  Google Scholar 

  75. Sullivan F. M., McElhatton P. R.: A comparison of the teratogenic activity of the antiepileptic drugs carbamazepine, clonazepam, ethosuximide, phenobarbital, phenytoin, and pyrimidone in mice. Toxicol Appl Pharmacol 40:365–378, 1977.

    Article  PubMed  CAS  Google Scholar 

  76. Jones K. L., Lacro R. V., Johnson K. A., et al: Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 320:1661–1666, 1989.

    Article  PubMed  CAS  Google Scholar 

  77. Dallesio D. J.: Seizure disorders in pregnancy. N Engl J Med 312:559–564, 1985.

    Article  Google Scholar 

  78. Cohen L. S., Heller V. L.: Manic depressive illness in pregnancy and the peurperium (letter). Psychosomatics, 1990, in press.

    Google Scholar 

  79. McElroy S. L., Keck P. E., Pope H. G., et al: Valproate in the treatment of rapid cycling mood disorder. J Clin Psychopharmacol 8:275–279, 1988.

    Article  PubMed  CAS  Google Scholar 

  80. Lindhout D., Schmidt D.: In utero exposure to valproate and neural defects. Lancet 1:329–393, 1986.

    Google Scholar 

  81. Schou M.: What happened later to the lithium babies: A follow-up study of children born without malformations. Acta Psychiatr Scand 54:193–197, 1976.

    Article  PubMed  CAS  Google Scholar 

  82. Cohen L. S., Rosenbaum J. F., Heller V. L.: Prescribing lithium for pregnant women (letter). Am J Psychiatry 145(6):773, 1988.

    Google Scholar 

  83. Weinstein M. R., Goldfield M. D.: Cardiovascular malformations with lithium use during pregnancy. Am J Psychiatry 132:529–531, 1975.

    PubMed  CAS  Google Scholar 

  84. Impasato D. J., Gabriel A. R., Lardara M.: Electric and insulin shock therapy during pregnancy. Dis Nerv Syst 25:542–546, 1964.

    Google Scholar 

  85. Wise M. G., Ward S. C., Townsend-Parchman W., et al: Case report of ECT during high-risk pregnancy. Am J Psychiatry 141:99–101, 1984.

    PubMed  CAS  Google Scholar 

  86. Repke J. T., Berger N. G.: Electroconvulsive therapy in pregnancy. Obstet Gynecol 63(suppl):39–40, 1984.

    Google Scholar 

  87. Remick R. A., Maurice W. L.: ECT in pregnancy (letter). Am J Psychiatry 135:761–762, 1978.

    PubMed  CAS  Google Scholar 

  88. Boyd J. H., Weissman M. M.: Epidemiology, in Paykel E. S. (ed): Handbook of Affective Disorders. New York, Guilford Press, 1982, p 6.

    Google Scholar 

  89. Istvon J.: Stress, anxiety, and birth outcome: A critical review of the evidence. Psychol Bull 100:331–348, 1986.

    Article  Google Scholar 

  90. Rementaria J. L., Blatt K.: Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatr 90:123–126, 1977.

    Article  Google Scholar 

  91. George D. T., Ladenheim J. A., Nutt D. J.: Effect of pregnancy on panic attacks. Am J Psychiatry 144:1078–1079, 1987.

    PubMed  CAS  Google Scholar 

  92. Cohen L. S., Rosenbaum J. F., Heller V. L., et al: Course of panic disorder in 24 pregnant women. Presented at the 142nd annual meeting of the American Psychiatric Association, San Francisco, May 11, 1989.

    Google Scholar 

  93. Rosenbaum J. F.: The drug treatment of anxiety. N Engl J Med 306:401–404, 1982.

    Article  PubMed  CAS  Google Scholar 

  94. Klein D. F.: Anxiety reconceptualized, in Klein D. F., Raskin J. (eds): Anxiety: New Research and Changing Concepts. New York: Raven Press, 1981.

    Google Scholar 

  95. Safra M. J., Oakley G. P.: Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 2:478–480, 1975.

    Article  PubMed  CAS  Google Scholar 

  96. Saxen I.: Association between oral clefts and drugs taken during pregnancy. Int J Epidemiol 4:37–44, 1975.

    Article  PubMed  CAS  Google Scholar 

  97. Laegreid L., Olegard R., Wahlstrom J., et al: Abnormalities in children exposed to benzodiazepines in utero. Lancet 1:108–109, 1987.

    Article  PubMed  CAS  Google Scholar 

  98. Winter R. M., Czeizel A., Lendvay A., et al: In-utero exposure to benzodiazepines. Lancet 1:627, 1987.

    Article  Google Scholar 

  99. Ballenger J. C.: Pharmacotherapy of panic disorders. J Clin Psychiatry 47(suppl 6):27–32, 1986.

    PubMed  Google Scholar 

  100. Cohen L. S., Rosenbaum J. F.: Clonazepam: New uses and potential problems. J Clin Psychiatry 48(suppl):50–55, 1987.

    PubMed  Google Scholar 

  101. Barry W. S., St. Clair S. M.: Exposure to benzodiazepines in utero (letter). Lancet 1:1436–1437, 1987.

    Google Scholar 

  102. Spier A. S., Tesar G. E., Rosenbaum J. F., et al: Clonazepam in the treatment of panic disorder and agoraphobia. J Clin Psychiatry 47:238–242, 1986.

    PubMed  CAS  Google Scholar 

  103. Pollack M. H., Tesar G. E., Rosenbaum J. F., et al: Clonazepam in the treatment of panic disorder and agoraphobia: A one year follow-up. J Clin Psychopharmacol 6:302–304, 1986.

    Article  PubMed  CAS  Google Scholar 

  104. Tesar G. E., Rosenbaum J. F., Pollack M. H., Sachs G. S., Herman J. B., Cohen L. S., Sidari J: Panic Disorder: Clonazepam versus alprazolam and placebo. New Research Section, American Psychiatric Association, 141 st Annual Meeting, Montreal, May 12, 1988.

    Google Scholar 

  105. Herman J. B., Rosenbaum J. F., Brotman, A. W.: The alprazolam to clonazepam switch for treatment of panic disorder. J Clin Psychopharmacol 7:175–178, 1987.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pregnancy Consultation Service, Clinical Psychopharmacology Unit, Massachusetts General Hospital, Boston, Massachusetts, 02114, USA

    Lee S. Cohen M.D.

  2. Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, 02115, USA

    Lee S. Cohen M.D. & Jerrold F. Rosenbaum M.D.

  3. Clinical Psychopharmacology Unit, Massachusetts General Hospital, Boston, Massachusetts, 02114, USA

    Jerrold F. Rosenbaum M.D.

  4. Department of Obstetrics and Gynecology, Beth Israel Hospital, Boston, Massachusetts, 02215, USA

    Vicki L. Heller M.D.

  5. Department of Obstetrics and Gynecology, Harvard Medical School, Boston, Massachusetts, 02115, USA

    Vicki L. Heller M.D.

Authors
  1. Lee S. Cohen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jerrold F. Rosenbaum M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vicki L. Heller M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Arizona Health Sciences Center, Tucson, Arizona, USA

    Alan J. Gelenberg M.D.

  2. The Better Homes Foundation, Newton Centre, Massachusetts, USA

    Ellen L. Bassuk M.D.

  3. Harvard Medical School, Boston, Massachusetts, USA

    Ellen L. Bassuk M.D.

  4. Schoonover Associates, Newton Centre, Massachusetts, USA

    Stephen C. Schoonover M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cohen, L.S., Rosenbaum, J.F., Heller, V.L. (1991). Psychotropic Drug Use in Pregnancy. In: Gelenberg, A.J., Bassuk, E.L., Schoonover, S.C. (eds) The Practitioner’s Guide to Psychoactive Drugs. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1137-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1137-0_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1139-4

  • Online ISBN: 978-1-4757-1137-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation